logo
Plus   Neg
Share
Email

Allergan Shareholders Oks Acquisition By AbbVie

Allergan plc (AGN) said Monday that a majority of its shareholders approved the proposed acquisition of Allergan by AbbVie Inc (ABBV).

Allergan stated that more than 99 percent of the votes cast at both a special court-ordered meeting of shareholders and at an extraordinary general meeting of shareholders were in favor of the transaction, representing about 68.6 percent of the shares outstanding and eligible to be voted at each of the Allergan shareholder meetings.

In June 2019, AbbVie agreed to acquire Allergan in a cash and stock transaction with an equity value of approximately $63 billion. The transaction is expected to close in early 2020, subject to customary closing conditions and regulatory approvals.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Billionaire Warren Buffett's Berkshire Hathaway reported a profit for the second-quarter that increased 87 percent from last year, as the value of its investment portfolio increased with the stock market. But it took about $10 billion write down on the value of its Precision Castparts aircraft parts unit due to the impact of the COVID-19 pandemic. Operating profit declined 10 percent. Twitter has had preliminary talks with TikTok's Chinese owner ByteDance to buy the U.S. operations of the video-sharing app, the Wall Street Journal reported citing people familiar with the matter. Meanwhile, Microsoft has been the only company so far to say publicly it is pursuing TikTok. Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients.
Follow RTT